Searched for
MOLBIO DIAGNOSTICS TARGETS
Motilal Oswal initiates coverage on Molbio Diagnostics stock with Buy, sees 21% upside. Here's whyMotilal Oswal initiated coverage on Molbio Diagnostics with a Buy rating and ₹1,800 target, implying 21% upside. The brokerage sees strong ...
Molbio Diagnostics shares rally 9% as Jefferies initiates 'high conviction top pick' call for recently listed stock. Why is it bullish?Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerag...
Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The ...
IPO rush: 5 companies to raise Rs 5,499 crore next week; Shiprocket, 4 others to listIndia’s IPO market enters another busy week, with five companies set to raise Rs 5,499.32 crore between August 17 and 21. Horizon Industria...
World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor roundMolbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...
Sebi gives approval to five IPO proposalsThe Securities and Exchange Board of India (Sebi) has given the green light for IPOs from Molbio Diagnostics, LEAP India, Foodlink F&B Hold...
From 'mild jaundice' to liver transplants: How Hepatitis A is turning deadly for adults in IndiaMumbai hepatologists are observing a shift in hepatitis infections. Hepatitis A is now causing severe illness in adults. New Hepatitis C ca...
One cough too many: India's TB fight isn't quite there yetDespite India's commitment to eliminate TB by 2025, the nation grapples with a significant burden of drug-resistant cases and underreportin...
Goa diagnostic company’s tuberculosis device could help scale up Covid-19 testingTruenat, a product of Molbio Diagnostics that’s been used to detect tuberculosis, also speeds up the reverse transcription polymerase chain...
Can coronavirus crisis change Indian science for good?It's unlike software. Vaccines, drugs and medical devices cannot be churned out overnight.